4.1. Interpharm Holdings (Real World Lens)
4.1. Interpharm Holdings (Real World Lens)
Diwa
MEM-611
4.1 REAL WORLD LENS (INTERPHARM HOLDINGS)
Interpharm is a manufacturer and distributor of generic drugs. The firm has nineteen
pharmaceutical products, representing eleven distinct drugs, some of which are sold at
different dosage levels. The firm in May 2003 sold its Atec Group, whose focus was
computer operations, in an effort to better focus the firm on its core competency
pharmaceuticals. The cash proceeds from that sale were $3.6 million. The firm then used
these proceeds to enhance its growth through internal innovation. The result was an
expansion of expenditures on R&D. These expenditures allowed the hiring of new
employees and the creation of better facilities. However, the promise of new products
was not immediately realized. In 2008, Amneal acquired Interpharm Holdings and will use
its outstanding management and financial strength to better realize the potential of
Interpharm s product line, to ensure the outcomes of its well-defined product pipeline, and
to leverage manufacturing capabilities. The development timeframe for pharmaceuticals
is very long. The inflow of cash in 2003 helped Interpharm but the firm needed still more
resources and time to realize its desired product development. The financial stability of
Amneal will help to realize these goals. The goal research and development of new
products remains the goal for the newly integrated Amneal and Interpharm.
1. What do you think about the changes to Interpharm Holdings fortunes in the last
decade?
The decisions they made will reflect on where there will be going on the next
decades. They should set a clear vision first that would allow them to know where
the company should be going to. The strategic plan that they have should be
maximize in order to achieve the key goals they have, but in their situation, it takes
time to release new products in the market. Having this, will affect the resources
and they have to apply process innovation to keep them in track.
2. Discuss the fit you see developing in Interpharm/Amneal’s internal innovation efforts
Maybe for now, the fruit of their labor is still not seen. But upon knowing the
strategies that they have; this will surely bring success and create an impact in
pharmaceutical industry. Taking the risk is hard, but proper management and
carefully taking the steps will enable them to move eventually forward.